latestage

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

2 months ago

Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock

October 15, 2025 17:15 ET  | Source: Annovis Bio Inc. MALVERN, Pa., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Annovis Bio,…

2 months ago

XORTX Completes USD $114,500 Private Placement

August 08, 2025 19:54 ET  | Source: XORTX Therapeutics Inc. NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR…

4 months ago

Spectral Medical Inc. Announces Filing of Base Shelf Prospectus

July 04, 2025 15:10 ET  | Source: Spectral Medical Inc. TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc.…

5 months ago

Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split

June 18, 2025 16:30 ET  | Source: Cellectar Biosciences, Inc. FLORHAM PARK, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Cellectar…

6 months ago

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

June 06, 2025 16:05 ET  | Source: PolyPid Ltd. PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD),…

6 months ago